Thyroid C-cell Tumors: In rodent scientific tests, semaglutide is shown to lead to thyroid C-mobile tumors. It's unknown whether or not this threat relates to people, but semaglutide is contraindicated in people with a private or loved ones history of medullary thyroid carcinoma (MTC) or patients with Multiple Endocrine Neoplasia syndrome kind two